Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-043873
Filing Date
2025-03-24
Accepted
2025-03-24 16:26:40
Documents
86
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bolt-20241231.htm   iXBRL 10-K 3323607
2 EX-19.1 bolt-ex19_1.htm EX-19.1 71760
3 EX-21.1 bolt-ex21_1.htm EX-21.1 4749
4 EX-23.1 bolt-ex23_1.htm EX-23.1 3255
5 EX-31.1 bolt-ex31_1.htm EX-31.1 14583
6 EX-32.1 bolt-ex32_1.htm EX-32.1 7534
  Complete submission text file 0000950170-25-043873.txt   12678134

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20241231.xsd EX-101.SCH 1485314
88 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20241231_htm.xml XML 2430145
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39988 | Film No.: 25764484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)